[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
June 9, 1999

Cost-effectiveness of Interferon Treatment for Hepatitis C—Reply

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;281(22):2083-2084. doi:10-1001/pubs.JAMA-ISSN-0098-7484-281-22-jbk0609

In Reply: Dr Henley raises important concerns about the scientific process. For any study, readers and peer reviewers must critically scrutinize the methods for validity and search for potential biases. However, governmental or nonprofit funding does not eliminate biases or conflicts of interest. Governments are often mindful of the implications of their studies and recommendations on limited resources and on politics. Professional organizations sometimes reflect the needs of their membership. These conflicts of interest can be complex; for example, an investigator working on a competing product could provide a harsh editorial, a biased manuscript review, or an unfavorable grant application review. Investigators, reviewers, and editors should disclose the existence of potential biases. Readers should consider the biases and their potential effects and interpret studies accordingly.

First Page Preview View Large
First page PDF preview
First page PDF preview
×